The Worldwide Grasp Course on Ageing Science (IMCAS) World Congress 2025 will happen from 30 January – 1 February in Paris, the place trade consultants will share the most recent scientific analysis and expertise innovation in dermatology, cosmeceuticals, ageing science, regenerative medication and cosmetic surgery.
This yr organisers count on greater than 18,700 contributors. The occasion is about to open with a convention that can embody subjects reminiscent of key trade tendencies, exosomes, AI for pores and skin most cancers prognosis, biohacking and regenerative medication, and world tendencies on GLP-1.
There may also be talks from IMCAS’ Scientific Administrators Hugues Cartier and Sebastien Garson.
Galderma to current new information
Among the magnificence trade’s largest gamers will likely be launching improvements on the occasion.
Swiss firm Galderma is about to current the most recent updates from its aesthetics portfolio and can share 10 analysis e-posters for its injectable aesthetic merchandise, together with Relfydess (RelabotulinumtoxinA), Sculptra and Restylane.
Alongside its group companions, Galderma may also host three symposia, a Masterclass, 5 Meet the Knowledgeable periods, and an interactive sales space targeted on its Relfydess product.
Galderma’s world head of R&D Baldo Scassellati Sforzolini MD PhD mentioned: “With such an in depth presence on the IMCAS congress this yr, now we have one other alternative not solely to share the most recent developments from our broad and revolutionary injectable aesthetics portfolio, but in addition to attach with the group in a significant manner, by data sharing and insights gathering.”
The brand new information will embody outcomes from a examine investigating the long-term aesthetic enchancment and topic satisfaction over 12 months following a single dose of Relfydess in sufferers with moderate-to-severe frown strains.
This examine reinforces beforehand introduced information, demonstrating that as much as 39% of sufferers see results from day one and as much as 75% of sufferers preserve enhancements for six months for frown strains and crow’s toes when handled with Relfydess.
Galderma may also current the most recent information on Sculptra, the “first confirmed regenerative biostimulator with a novel poly-L-lactic acid (PLLA-SCA™) formulation.”
New information reinforces its regenerative properties and results throughout all three pores and skin layers, underscoring its key position within the regenerative aesthetics subject, together with its profit compared to different merchandise.
Research recommended Sculptra stimulated the important thing elements of the pores and skin, together with collagen, elastin and adipose tissue, and strengthened its security profile.
One other comparative examine discovered synergistic results for the midface when pairing Sculptra with Alastin®, with an enchancment in getting older pores and skin and affected person expertise when utilizing each.
L’Oréal to deal with longevity science
The French multinational L’Oréal may also be current on the world congress.
Audio system will embody: Luc Aguilar from L’Oréal’s R&D division who will focus on ‘the science of longevity, whereas Frederic Flament, additionally from its R&D division, will discover pores and skin longevity (together with atlases, AI-driven diagnostic, invisible biomarkers evaluation).
Friends may also hear from Natalia Kovylkina of Vichy, who’s a collagen specialist, and Annie Black from the Lancôme model, who will discuss boosting mitochondrial perform for pores and skin longevity
Julie Faitg from biotech agency Time Line, which L’Oréal invested in a single yr in the past, may also be part of the road as much as focus on concentrating on mitochondrial well being to spice up pores and skin healthspan and longevity with ‘mitopure’®.
Unilever to speak about exosomes and pores and skin microbiome
UK multinational Unilever can also be set to current a symposium on the congress, which is able to cowl sizzling subjects within the skincare class from exosomes to microbiome.
